Virtu Financial LLC Cara Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

A detailed history of Virtu Financial LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 58,094 shares of CARA stock, worth $26,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,094
Previous 75,987 23.55%
Holding current value
$26,723
Previous $20,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024
SELL
$0.26 - $0.38 $4,652 - $6,799
-17,893 Reduced 23.55%
58,094 $18,000
Q2 2024

Aug 09, 2024
BUY
$0.24 - $0.92 $18,236 - $69,908
75,987 New
75,987 $20,000
Q1 2023

May 01, 2023
BUY
$4.89 - $12.27 $100,645 - $252,541
20,582 New
20,582 $101,000
Q4 2020

Feb 24, 2021
SELL
$12.72 - $16.16 $170,091 - $216,091
-13,372 Closed
0 $0
Q3 2020

Dec 11, 2020
BUY
$12.34 - $17.92 $165,010 - $239,626
13,372 New
13,372 $170,000
Q1 2019

Apr 12, 2019
SELL
$14.41 - $19.64 $278,343 - $379,366
-19,316 Closed
0 $0
Q4 2018

Jan 16, 2019
BUY
$12.45 - $23.47 $105,775 - $199,401
8,496 Added 78.52%
19,316 $251,000
Q3 2018

Nov 13, 2018
SELL
$17.57 - $23.95 $8,767 - $11,951
-499 Reduced 4.41%
10,820 $259,000
Q1 2018

May 14, 2018
BUY
$11.77 - $16.08 $133,224 - $182,009
11,319 New
11,319 $140,000
Q4 2017

Feb 09, 2018
SELL
$11.86 - $14.08 $206,126 - $244,710
-17,380 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$12.6 - $16.34 $218,988 - $283,989
17,380
17,380 $0

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $24.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email